← peptides typeshit

Laurus Labs CEO Satyanarayana Chava on CDMO growth, peptides and margins

Chava talks through capacity investment as the CDMO business grows, with peptides part of the plan and margins near 30% in focus.

See it on X

Recap by typeshit. Post by Wegro App on X.